Olanzapine (Zyprexa in the U.S.) is an atypical antipsychotic manufactured by Eli Lilly and Company that has been used as an antipsychotic drug since 1996. The FDA has approved its use in the treatment of schizophrenia, acute or mixed manic episodes of bipolar I disorder, and for maintenance treatment of bipolar disorder (1). The normal adult dosage is 10-20 mg, and the drug is available in once-daily tablets of 2.5-20 mg, as well as 2.5-20-mg tablets that dissolve on contact with saliva (Zyprexa Zydis) and intramuscular injections (2). Olanzapine is structurally and functionally similar to clozapine, and both are classified as thienobenzodiazepines. Olanzapine has a high affinity for a large number of receptors in the central nervous system including serotonin, dopamine, adrenergic, and muscarinic cholinergic receptors (3). Reported side effects include weight gain, sleepiness, constipation, dry mouth, increased appetite, feeling weak, upset stomach, tremors, dizziness, and problems in body temperature regulation (4). Olanzapine is not approved for use in elderly patients with dementia-related psychosis because of an increased risk over control groups of cardiovascular or infectious deaths (4.5% vs. 2.6% for placebo group) (5). Hyperglycemia has been associated with taking atypical antipsychotics, including olanzapine, and deaths from hyperglycemia from therapeutic dosages of olanzapine have been published (6).
Introduction
Olanzapine (Zyprexa in the U.S.) is an atypical antipsychotic manufactured by Eli Lilly and Company that has been used as an antipsychotic drug since 1996. The FDA has approved its use in the treatment of schizophrenia, acute or mixed manic episodes of bipolar I disorder, and for maintenance treatment of bipolar disorder (1) . The normal adult dosage is 10-20 mg, and the drug is available in once-daily tablets of 2.5-20 mg, as well as 2.5-20-mg tablets that dissolve on contact with saliva (Zyprexa Zydis) and intramuscular injections (2) . Olanzapine is structurally and functionally similar to clozapine, and both are classified as thienobenzodiazepines. Olanzapine has a high affinity for a large number of receptors in the central nervous system including serotonin, dopamine, adrenergic, and muscarinic cholinergic receptors (3) . Reported side effects include weight gain, sleepiness, constipation, dry mouth, increased appetite, feeling weak, upset stomach, tremors, dizziness, and problems in body temperature regulation (4). Olanzapine is not approved for use in elderly patients with dementia-related psychosis because of an increased risk over control groups of cardiovascular or infectious deaths (4.5% vs. 2.6% for placebo group) (5) . Hyperglycemia has been associated with taking atypical antipsychotics, including olanzapine, and deaths from hyperglycemia from therapeutic dosages of olanzapine have been published (6) .
The purpose of this study was to provide additional data about postmortem concentrations and redistribution of olanzapine to help in interpretation. Varying olanzapine concentrations have been reported as being toxic, but few authors cite postmortem liver or vitreous concentrations, and there still seem to be large variations in the concentrations reported as toxic. Stephens and co-workers (7) published a blood concentration of 1.24 mg/L. Elian and colleagues (8) reported a blood concentration of 4.9 mg/L. Levine and co-workers (9) reported a blood concentration of 0.98 mg/L. Merrick and colleagues (10) reported a heart blood concentration of 0.40 mg/L and a liver concentration of 0.61 mg/kg. Horak and co-workers (11) described a heart blood concentration of 1.38 mg/L, femoral blood concentration of 1.11 mg/L, and liver concentration of 6.47 mg/kg. Chue and colleagues (12) cite multiple olanzapine concentrations related to toxicity, with a mean of six cases from the Alberta Medical Examiner's Office being 1.81 mg/L in blood and 30.8 mg/kg in liver. Concentrations in postmortem blood as low as 0.160 mg/L of olanzapine have been cited as a concentration at which olanzapine toxicity may become an issue in cause of death (13) .
Materials and methods
Olanzapine standards and controls were made from powdered stock obtained from Eli Lilly (Indianapolis, IN) and made from separate lot numbers. The internal standard used was cyclizine (Burroughs-Wellcome, Kirkland, QC, Canada). Both olanzapine and cyclizine were prepared in 1.0 mg/mL stocks in methanol. Working stock solutions of olanzapine were prepared in deionized (DI) water at a concentration of 1.0 mg/L for both the standard and control. Ascorbic acid was made at a concentration of 2% from solid 100% ascorbic acid (Malinkrodt, Paris, KY). The cyclizine was diluted with DI water to make 5.0 mg/L working solution. 1-Chlorobutane and ethyl acetate are manufactured by OmniSolv. Concentrated hydrochloric acid is manufactured by Aristar and the concentrated ammonium hydroxide is from EMD. Sodium sulfate (anhydrous, granular ACS grade) was obtained from SigmaAldrich Chemical (St. Louis, MO).
Olanzapine was first detected in a basic drug screen by gas chromatography-mass spectrometry (GC-MS) using a liquid-liquid extraction for blood. Any detected olanzapine was then quantitated on a GC with a selective nitrogen-phosphorus detector (NPD). Five-point calibration curves were obtained by making calibrators from the working olanzapine solution in the concentrations of 0.1, 0.25, 0.5, 1.0, and 2.0 mg/L. Two controls were made from a separate working stock with a different lot number in concentrations of 0.5 mg/L each. A curve was constructed for each separate matrix.
Olanzapine specimens were analyzed using an HP 5890 series II Plus GC using a DB-17 (15 m × 0.252 mm × 0.25 µm) column from Agilent and a nitrogen-phosphorus bead detector, also from Agilent. Helium was the carrier gas and had a flow rate of 1.2 mL/min. For all samples, the inlet temperature was set to 250°C and the detector set at 280°C. For all samples, 1 µL of sample was injected on the column, and after 30 s, the GC started its oven ramp. The oven started at 50°C, and the ramp was an increase of 35°C/min for 4.5 min. After 4.5 min, the oven temperature remained constant at 275°C until the end of the run. Total runtime after injection was 11.4 min. The cyclizine internal standard eluted at 6.271 min and olanzapine had a retention time of 9.618 min within a window of 1% and a relative retention time of 1.533. An example of a typical chromatogram is shown in Figure 1 .
Extraction
Samples were all extracted using a modified Foerster-Garriott procedure (14) . For all blood and vitreous samples, the acid back-extraction step was skipped due to variable recoveries of olanzapine. Liver specimens were homogenized with an equal amount of DI water to create a 0.5 g/mL homogenate. Concentrations of all blood and gastric specimens were calculated from a blood curve with their own calibrators, controls, blank and negative, and all liver and vitreous concentrations were calculated with their matching matrix calibrators as well. Cyclizine internal standard was added to each tube except blanks. Each tube then had 200 µL of 2% ascorbic acid added to stabilize and increase recovery of olanzapine, which decreases over time during storage from olanzapine oxidation per O'Keefe and co-workers (15) . Concentrated ammonium hydroxide was then added to each tube, followed by adding 1-chlorobutane, then extraction by rotation. Tubes were centrifuged and if the specimens were blood or vitreous, extraction was completed and the 1-chlorobutane layer was transferred to culture tubes to be evaporated at 37°C under nitrogen gas to dryness. Dry extracts were reconstituted with 300 µL of ethyl acetate and then pipetted into autosampler vials fitted with glass volume inserts. For liver curves, the acid back-extraction step with hydrochloric acid was used. Following the back-extraction, the samples were centrifuged and the organic 1-chlorobutane layer was aspirated to waste. The samples were made basic again with ammonium hydroxide and extracted into chlorobutane, and after extraction and centrifugation, the organic phase was removed. The solvent was evaporated at 37°C under nitrogen gas to dryness and reconstituted with 100 µL of ethyl acetate and transferred to autosampler vials.
Calibration/controls
Calibrators used were back-calculated to original known concentrations and were within 20% of target value. Calibration curves were constructed from a maximum of five and a minimum of four non-zero points (an example is shown in Figure 2 ), and the origin was included if possible. Calibrators were dropped if the calibrator was off by more than 20% from the theoretical spiked concentration, or if dropping of the calibrator would bring the remaining four points into acceptance criteria for the linear regression fit. The calibration curve used a linear regression fit (r 2 ≥ 0.99). Both control samples were calculated and compared to the known value of 0.5 mg/L. All specimen tubes were diluted, so concentrations would be expected to fall within the range of the calibration curve. Accuracy of the method was established with 20 analyses over 2 years and was 99% with a standard deviation of ± 0.057 mg/L for an olanzapine concentration of 0.50 mg/L. Precision of the method was established over the same period with the same samples, and the coefficient of variation was 11% for an olanzapine concentration of 0.50 mg/L. Concentrations below the lowest calibrator were not reported. A minimum of two dilutions was used for tissue samples, and dilutions were within 20% of one another.
Case Histories

Case #1
A 54-year-old Caucasian man had a history of Fragile X syndrome and was clinically mentally retarded. He went to a nearby restaurant and reportedly became fidgety and woozy, and staff members took him to the restroom. While seated on the toilet, he became pale and weaker, and an ambulance was summoned. He was declared dead approximately one halfhour after the incident. His medical history included lactose intolerance, dermatitis, mild diverticulosis, and past gastrectomy due to gastrointestinal bleeding. He was known to have been prescribed Lomotil, Accutane, calcium, and Paxil. Autopsy revealed no injuries or clear anatomic cause of death. Cause of death was found to be sudden cardiac arrest, unknown etiology.
Case #2
An 86-year-old Hispanic male was found collapsed in his bedroom by his wife. He had a history of previous myocardial infarcts and was reportedly reluctant to take his prescribed medications. His wife reported that he was becoming increasingly more agitated. No medications were impounded. Autopsy revealed ischemic changes, interstitial hemorrhage, and severe coronary disease; sections of lung showed chronic obstructive pulmonary disease, acute congestion, and diffuse alveolar damage. Cause of death was found to be acute myocardial infarcts.
Case #3
A 42-year-old man with a long history of bipolar disorder/ schizophrenia was admitted to a psychiatric unit for control of psychotic behavior. He was reported to have become aggressive and began pounding on the walls and doors of his room with his hands, head, and feet. He was walked to a seclusion room and given an injection of Ativan, but was not restrained. He was checked every 15 min and went back and forth between lying on the bed and the floor in the unlocked room. He refused to go to dinner, at which time he spoke to a nurse. At 1800 he was laying prone on the floor. At approximately 1830 he was found to be unresponsive, and resuscitation was unsuccessful. His medical history and drug and alcohol use history were unknown. His medications were noted to be lithium, Welbutrin, Paxil, Zyprexa, and Klonopin. Autopsy revealed generalized organ congestion with intense congestion of the leptomeninges and diffuses subarachnoid hemorrhage. Cause of death was found to be subarachnoid hemorrhage (etiology undetermined).
Case #4
A 49-year-old woman with a history of unspecified psychiatric disorder, heart disease, and seizure disorder following a remote motor vehicle accident complained of feeling tired and weak, and collapsed in the bathroom. Approximately two weeks before her death she developed an upper respiratory infection and was diagnosed with pneumonia. Resuscitation was unsuccessful. Autopsy revealed residual organizing pneumonia with an abscess in the right middle lobe and considerable pleuritis on this side, as well as a small pleural effusion/exudate and evidence of more diffuse adult respiratory distress syndrome (ARDS). In addition to the pneumonia and ARDS, the lungs showed chronic bronchitis, fibrosis, anthracosis, and emphysema consistent with chronic obstructive pulmonary disease. The heart showed focal moderate atherosclerosis of the left coronary artery and an aberrant, narrowed origin of the right coronary artery, with a subacute infarct (heart attack) consistent with being at least several weeks in age in the posteromedial left ventricle. Cause of death was found to be ARDS, pneumonia with abscess formation, and chronic obstructive pulmonary disease, with significant contributing factors of acute methamphetamine intoxication, focal coronary atherosclerosis, aberrant origin of right coronary artery, and clinical post-traumatic seizure disorder.
Case #5
A 58-year-old male was reportedly mentally disabled and lived with two friends in a house. He was found dead in bed by his roommates. His medical history was significant for an unspecified type of psychosis and depression. Prescription medications impounded by the Medical Examiner's Office include Zyprexa (20 mg 1/day, 11 pills missing, prescription 14 days old), Lipitor, Paxil, and Avandia. Autopsy revealed marked coronary artery atherosclerosis and evidence of hypertension. The decedent had also had his right kidney removed some time in the past. Evidence of heart failure, including peripheral edema and a right pleural effusion, was noted. Cause of death was found to be coronary artery arthrosclerosis.
Case #6
A 58-year-old woman who was a resident of a board and care facility whose medical history included schizophrenia and a head injury from an accident 1 year prior had a witnessed collapse the morning of her death. She could not be resuscitated. She was currently taking the medication Zyprexa. Autopsy revealed findings consistent with the history. There were some minor injuries, but no evidence that her death was related to any type of trauma. The heart showed moderate to severe twovessel coronary artery disease and microscopic evidence of ischemic damage, which would account for her sudden collapse. The colon showed considerable dilation with focal necrosis and inflammation, which probably related to her underlying psychiatric disease. Cause of death was found to be sudden cardiac arrest.
Case #7
A 41-year-old man with a history of chronic alcoholism and bipolar disorder was found dead in the tent where he lived on his brother's property. When last seen the previous evening, he had appeared intoxicated. He was known to be taking Lexapro and Zyprexa. Autopsy revealed a severely enlarged liver as a result of severe fatty change, consistent with chronic alcoholic liver disease. The heart showed moderate left ventricular hypertrophy, consistent with hypertension and/or alcoholic cardiomyopathy. There was no significant trauma. Cause of death was found to be acute and chronic alcoholism.
Case #8
A 59-year-old woman who had a history of mental retardation and organic brain disorders was apparently struck by a pickup truck while she was a pedestrian crossing a street. Autopsy revealed documented multiple blunt force injuries including multiple pelvis, cranium, rib, and extremity fractures and internal organ lacerations. Cause of death was found to be multiple blunt force injuries.
Case #9
A 39-year-old single white female with a history of schizophrenia was found dead in her condominium by her parents during a welfare check. Police and paramedics were summoned, and they confirmed death following CPR efforts. She was known to have been prescribed Zyprexa, Lexapro, and Lunesta. Autopsy revealed sections of the skin, including breast and scalp, where injuries were evident showed fresh hemorrhage without reactive change. Sections of the brain showed scattered areas of parenchymal hemorrhage, especially around the brainstem. Cause of death was found to be closed head blunt force injuries.
Case #10
A 37-year-old man who had a history of alcoholism, remote drug abuse, and manic depression with multiple past statements of suicidal ideation told the parent with whom he lived that he had taken "poison". The next day, he was noted to be breathing strangely and to be partially off his bed. Later in the afternoon, he was found kneeling on the floor with his face pressed against the carpet, dead. Multiple prescription bottles and spilled pills [identified as olanzapine (Zyprexa) 10 mg 1/day, 192 pills missing total from 3 containers; prescriptions were 3, 5, and 6 months old, respectively] were found in the room. Autopsy revealed a minimally enlarged heart with focal moderate coronary atherosclerosis of the left anterior descending coronary artery, but no other significant natural disease or trauma. There was generalized organ congestion, and the stomach contained residual partially dissolved medication. Cause of death was found to be acute olanzapine intoxication.
Case #11
A 26-year-old man had a history of depression/bipolar disorder with prior suicide attempts, including a suicidal overdose two years before his death. He was admitted to a behavior health unit at a local hospital with depression and suicidal ideation and continued to be suicidal and spent much of his time sleeping throughout his hospitalization. In the morning he was found to be unresponsive when he could not be awakened. Resuscitation was unsuccessful. He was known to have been placed on Zyprexa (20 mg), Luvox, and Ambien while in the hospital. Autopsy revealed generalized organ congestion, but no significant natural disease or trauma to account for the death. The presence of a distended urinary bladder and early pneumonia on microscopic examination of the lungs was consistent with his having had a decreased level of consciousness for hours before death. Cause of death was found to be acute fluvoxamine, oxycodone, and olanzapine intoxication.
Case #12
A 36-year-old woman with a history of bipolar disorder, asthma, migraine headaches, and fibromyalgia was on numerous medications. She had a history of remote suicidal overdoses and more recent accidental drug overdose. She was noted slumped over her computer. Nine hours later, she was observed in the same position and confirmed dead after being moved. Prescription medications found at scene included Lipitor, Soma, Prevacid, Allegra, metronidazole, clonazepam, propoxyphene, carbamazepine, buspirone, Celexa, and Zyprexa (15 mg 1/day, 7 pills missing, prescription 15 days old). Autopsy revealed generalized organ congestion, pulmonary edema, and obesity associated with mild left ventricular hypertrophy of the heart and enlargement of the liver, but no significant natural disease or trauma were found to account for the death. Cause of death was found to be citalopram, propoxyphene, carisoprodol, carbamazepine, acetaminophen, and olanzapine intoxication.
Case #13
A 25-year-old woman who had recently been released from a psychiatric care facility with a diagnosis of paranoid schizophrenia reportedly drank an excessive amount of alcohol and passed out at a friend's house. She fell twice during the course of the evening. Her friends found her unresponsive on the bedroom floor where she had been put to "sleep it off". Paramedics were called, and she was pronounced dead at the scene. Her prescription medications included lithium, Zyprexa (10 mg, 19 pills missing), risperdal, Lexapro, Ambien, temezepam, naproxen, and methocarbamol. Autopsy revealed acute bronchopneumonia of the right lung and bilateral pulmonary congestion. The decedent had no external head injuries and had only a minor contusion on her right scalp that would not have contributed to her death. Cause of death was found to be ethanol, temezepam, olanzapine, dextromethorphan, citalopram, and zolpidem intoxication.
Case #14
A 46-year-old man whose medical history was significant for manic depression with disability, schizophrenia, and a history of seizures, had previously overdosed with medicines while an in-patient in a psychiatric home. He went to his mother's house to spend the night after having problems with his girlfriend. When his mother awoke in the morning she found him unresponsive in bed. Emergency Services was called and his death was confirmed. No suicide note was immediately found. Medications prescribed to him included Zyprexa (15 mg), Wellbutrin SR, BuSpar, and doxepin. Autopsy revealed pulmonary emphysema and medication residue in his stomach and duodenum. He also had multiple linear scars on his wrists. Cause of death was found to be doxepin, bupropion, methamphetamine, and olanzapine toxicity.
Case #15
A 78-year-old woman with no history of alcohol or prescription medication abuse was found dead in the bed of her residence. She was diagnosed with depression and anxiety after her husband's death. She was on a number of different prescription medications, including mirtazapine, Zoloft, amitriptyline, Ambien, lorazepam, Lexapro, trazodone, Zyprexa (2.5 mg 1/day, 30 pills missing, prescription 2 months old and 10-mg sample packs, unknown quantity missing), phenytoin, and acyclovir. A handwritten note, which read "SORRY FOR THE MESS", was found. Empty medication containers were found in a trash can, including olanzapine. Autopsy revealed early decompositional changes. The right lung had acute pneumonia. There was no evidence of trauma. Cause of death was found to be acute olanzapine intoxication.
Case #16
A 49-year-old woman who lived with her daughter had a medical history of chronic bowel pseudo-obstructions with free air, malabsorption syndrome, chronic Total Parenteral Nutrition, and anemia. The disorder caused her pain, for which she was prescribed pain medications. A side effect of these medications was constipation, which exacerbated her pseudoobstruction. She reported that she was not feeling well, and appeared to be in a "daze." She refused to go to the hospital. When she did not leave her bedroom the following day, her daughter checked on her and found her unresponsive in bed. Emergency Services was called, and responding paramedics attempted resuscitation. Despite this, she was declared dead at her home after several minutes. Medications collected included Singulair, Remeron, Fentanyl Duragesic patches, hydromorphone, Nefazodone, amitriptyline, prochlorperazine, lorazepam, Geodon, flurazepam, Zyprexa (7.5 mg), Wellburtin, Prevacid, famotidine, and metoclopramide. Autopsy revealed marked dilation and distention of the proximal small intestines including the jejunum and proximal ileum. There was gas in the bowel wall (pneumointestinalis), but no discernible free gas in the abdomen. The distal ileum and colon were of normal caliber. No anatomic obstruction was identified. There were no mass lesions or ulcers. Microscopic examination of the bowel wall revealed clear spaces consistent with the gas, but no inflammation or other histopathology. Cause of death was found to be acute combined fentanyl, bupropion, mirtazapine, and olanzapine intoxication, with contributing chronic idiopathic small bowel pseudo-obstruction.
Case #17
A 52-year-old Caucasian woman, who had a history of depression, severe insomnia, and tinnitus, had earlier been committed to a mental rehabilitation center for five days for threatening to kill herself on an almost daily basis, and when she could no longer afford the medical bills was released to go home. Her boyfriend arrived home from out of town early because he was concerned, and he found her dead in bed. She had told her boyfriend she was tired of dealing with depression and she wanted him to "just let go". The prior morning, the boyfriend witnessed her putting several pills in her mouth. Several empty Ambien bottles were present. She was reported to have been prescribed Ambien and Zyprexa (5 mg, 5 pills missing). Autopsy revealed a relatively healthy-appearing woman with no significant injuries and no natural disease except for a slightly enlarged heart. Cause of death was found to be acute olanzapine and zolpidem intoxication.
Case #18
A 53-year-old man with a history of schizoaffective disorder was found dead in his apartment during a welfare check initiated by the complex manager when he was not seen the previous morning. He was pronounced dead at the scene without resuscitation by paramedics. No other medical or social history is known. Autopsy revealed moderate putrefied state with no traumatic injuries. Internal examination documented pulmonary emphysema with honeycombing, bleb formation, and marked pleural adhesions. The heart had biventricular dilatation. The kidneys had benign nephrosclerosis consistent with hypertensive cardiovascular disease. There was hepatic steatosis and evidence of remote laparotomy and left craniotomy with a small amount of subdural neomembrane. Cause of death was found to be acute intoxication by the combined effects of chlorpromazine, olanzapine, amitriptyline, tramadol, hydrocodone, and zolpidem.
Case #19
A single, unemployed 52-year-old white male with a history of schizophrenia, digestive disorders, and diverticulitis was found unresponsive in his residence and pronounced a short time later. He had always had problems with his digestion, but in the last two weeks, he was complaining of loss of appetite, generalized abdominal discomfort, and in the last three to four days, severe constipation. Contrary to his habitual reticence to be seen by a doctor, he asked his sister to take him to a hospital because of an increased onset of abdominal pain.
Known prescribed medications include ciprofloxacin, metronidazole, and Zyprexa (20 mg 1/day, 23 pills missing, prescription 22 days old). Autopsy revealed coronary artery atherosclerosis and acute pulmonary congestion and edema. Cause of death was found to be olanzapine toxicity.
Case #20
A 27-year-old man who had a history of depression and was on several antidepressant medications was found dead facedown on the floor of the bathroom where he often slept on hot nights. He was last seen alive the night before when he had gone into the bathroom. Medications impounded at the scene included fluoxetine, Zyprexa (2 pills missing), Lexapro, and Kemadrin. Autopsy revealed early decompositional changes and abundant purge on the face as well as postmortem damage to the skin of the face from exposure to gastric acid and purge. There was no natural disease or trauma identified. Cause of death was found to be fluoxetine and olanzapine intoxication.
Case #21
A 39-year-old single white male with a history of life-long schizophrenia with poor prescribed medication compliance was found dead in his residence by his mother during a welfare check after she was unable to contact him for approximately a week. He was found prone on the floor of the residence bedroom with early decomposition changes and prescribed pills and pill bottles scattered. There is no significant family medical history. He was known to have been prescribed Zyprexa (20 mg 1/day, 3 containers of 30 pills with a total of 37 pills missing, of which the prescriptions were 3, 2, and 1 month old) and trihexylphenidyl. Autopsy revealed recent superficial abrasion/contusions of the right side of forehead, ear, face, neck, anterior shoulder, and right arm with no underlying skeletal or visceral injuries, and acute pulmonary congestion and edema. Cause of death was found to be ethanol, olanzapine, and methamphetamine intoxication.
Case #22
A 32-year-old man lived alone in an independent living facility. He had a history of schizoaffective disorder, heavy alcohol use, marijuana use, and a recent admission to a behavioral health facility, possibly because he wanted to die. He was found dead on the floor of his room by his apartment manager. There were several empty bottles of medications in the room. He was known to have been prescribed a 30-day supply at the behavioral health facility of Seroquel, Zyprexa (10 mg 1/day, all 30 pills missing, prescription 22 days old), Lexapro, trazadone, Benadryl, and Dilantin, all of which were found empty. Autopsy revealed no significant injuries. The heart exhibited moderate biventricular dilation. There were possible pill fragments in the stomach. Cause of death was found to be acute diphenhydramine, quetiapine, citalopram, trazadone, olanzapine, and phenytoin intoxication.
Case #23
A 33-year-old with a history of hypertension, elevated cholesterol, schizophrenia, cigarette smoking, alcohol abuse, and illicit drug abuse was found fully clad and decomposing in the bathroom of his residential hotel room. He was known to be on atenolol and Zyprexa, but only the atenolol was found at the scene. No illicit drugs or drug paraphernalia were identified. Autopsy revealed generalized organ congestion and a dilated urinary bladder, but there was no significant natural disease or trauma to account for the death. Cause of death was found to be acute olanzapine intoxication.
Case #24
An unemployed 58-year-old Caucasian man with a history of a pacemaker placed for a heart block, hepatitis C, alcohol abuse, schizophrenia, hyperlipidemia, normocytic anemia, urethral stricture status post-dilation, squamous cell cancer status post-removal, and scabies was found by housekeeping staff on the floor of his hotel room. Approximately two or three days prior to his death, he was heard "banging around in his room" and was witnessed to be apparently under the influence of something shortly thereafter. There was evidence of alcohol use. The following prescription medications were impounded: alprazolam, fluoxetine, Zyprexa (15 mg 2/day, 22 pills missing, prescription 1 month old), Depakote, famotidine, hydrocodone, and Augmentin. Autopsy revealed scattered bruises of varying ages on his arms, legs, and torso. There was also a recent rib fracture on the left side but no blood in the chest cavity or pneumonia. There was a pacemaker and moderate to marked coronary disease of the left anterior descending. The liver exhibited early cirrhosis. There was only a small amount of liquid in the stomach, as well as four coins. Cause of death was found to be acute amitriptyline, olanzapine, and fluoxetine intoxication.
Case #25
A 36-year-old man with a history of paranoid schizophrenia, hypertension, frequent headaches, and kidney failure was found unresponsive slumped over on the bed of his residence and was confirmed dead at the scene without medical intervention. He was reportedly not compliant with his medications. Several old prescription medications were found, and bottles of Zyprexa (15 mg 1/day, 2 containers of 60 pills each were empty, prescriptions 7 and 9 months old) and Lipitor were empty. No suicide note was found. Autopsy revealed no evidence of significant recent trauma. The heart was not enlarged but had moderate one-vessel coronary artery disease. Cause of death was found to be acute olanzapine intoxication.
Case #26
A 42-year-old man with a history including drug abuse and a previous history of overdosing was a transient, but he was temporarily staying at a relative's house. In the evening, he appeared to be under the influence of alcohol or drugs and did not appear well. He went to bed and was snoring loudly. The next morning, he was found dead in bed. He had also apparently had a previous suicide attempt by injecting bleach into his veins. Several prescription medications were found at the scene. No drugs, paraphernalia, or suicide-type notes were found. Medications found in his backpack were Zyprexa (20 mg 1/day 23 pills missing, prescription 19 days old), Lexapro, Lunesta, Seroquel, Vistaril, and Depakote. Autopsy revealed Methamphetamine 0.08 mg/L methamphetamine intoxication Liver 12 Vitreous 2.1 Gastric < 1 * All blood and vitreous levels in mg/L; all liver levels in mg/kg; all gastric levels in mg. † PB = Peripheral blood. ‡ CB = Central blood. § ND = Not detected no evidence of recent trauma, moderate severely pulmonary edema, chronic portal inflammation of liver with mild steatosis, and minimal atherosclerotic disease. Cause of death was found to be acute olanzapine and quetiapine intoxication.
Case #27
A 41-year-old Caucasian woman had a history of schizophrenia, chronic alcohol abuse, depression, and reportedly a "heart surgery" approximately two years prior. She lived with her parents off and on and had recently moved in with a friend. Her parents were on a two-week vacation, then came home and went directly to bed. Later that morning, the decedent was found unresponsive in the parents' backyard. She was pronounced dead at the scene without resuscitation. According to her parents, she had a history of visiting their house and passing out in the yard. The decedent was found on the patio in an early putrefactive state with three small white pills next to her body. She was known to be taking Effexor, Amblify, Zyprexa, along with other unknown pills. Autopsy revealed no traumatic injuries. Internal examination documented complications of chronic alcohol abuse including moderate hepatic steatosis and pancreatic saponification and delicate fibrosis. The heart showed decomposition artifact with no hypertrophy, dilatation, or obvious scar tissue. An incidental benign nodule was found along the gastroesophageal junction consistent with a smooth muscle tumor. There was no other significant natural disease. Cause of death was found to be acute olanzapine intoxication.
Case #28
A 39-year-old man with a lifelong history of profound mental retardation and autism was found unresponsive on the living room floor of his care facility. He had demonstrated obsessive-compulsive, aggressive, and destructive behavior, for which he was on multiple psychotropic medications and all of which were administered by the staff of the board and care home where he lived. He also had choking episodes due to his behavior disorder, and at some point he was also diagnosed with gastroesophageal reflux disease. He required monitoring because of a history of excessive and compulsive fluid consumption. His current medications included trazadone, Seroquel, fluoxetine, benztropine, Zyprexa (10 mg), propranolol, carbamazepine, Bactracin, milk of magnesium, and docusate sodium. His medications were kept in a locked closet and administered by the staff. He was hospitalized for five days after ingesting a pair of gloves (probably latex), which were removed from his stomach during an exploratory laparotomy after they were visualized on endoscopy for heartburn. There was no history of seizures, heart disease, or asthma. Autopsy examination documented emesis on his clothing and evidence of gross terminal aspiration of this material into only the lower lobe of the right lung, probably as a result of the resuscitative efforts. The large airways were not occluded. The lungs were slightly hyperexpanded. On microscopic examination, they demonstrated the classic changes of acute and chronic bronchial asthma, including peribronchial inflammation, thickening of the bronchial mucosal basement membranes, increased numbers of mucus cells in the mucosa, and thickening of the peribronchial smooth muscle with contraction of the bronchioles and mucus plugs. There was no other significant anatomic natural disease or trauma to account for the death. The manner of death was classified as natural.
Results
The standard procedure for analysis of postmortem blood specimens in the San Diego County Medical Examiner's Office was to first screen for simple volatiles by GC with a flame ionization detector, to screen for drugs of abuse (cocaine, methamphetamine, opiates, benzodiazepines, fentanyl, and THC) by immunoassay (ELISA), to screen for basic drugs by GC-MS, and to screen for acid/neutral drugs by high-pressure liquid chromatography with a photodiode array detector. Detection of olanzapine in a specimen by GC-MS necessitated further analysis and confirmation by GC-NPD. If the positive olanzapine case had central blood, liver, gastric, or vitreous samples in addition to peripheral blood run, then those specimens were also run by GC-NPD. The results obtained for each case, along with the cause and manner of death and any additional drugs and amounts of those drugs detected is shown in Table I . The cases were divided into three groups as shown in Table II : those that were not drug-related (or in 2 cases were drug-related but did not cite olanzapine) and were consistent with therapeutic use of olanzapine; those that were multi-drug drug-related deaths and cite olanzapine as one of those related drugs; and those where cause of death was attributed solely to olanzapine. Mean and standard deviations for the reported levels are summarized in Table II .
Postmortem redistribution data was calculated for peripheral blood (PB)/central blood (CB), vitreous/PB, and liver/PB ratios. Including all samples, PB/CB ratios averaged 0. Tables III and IV for everything except the liver/PB ratio, which on splitting the combined table into three separate tables, showed that the non-olanzapine death segment was skewing the overall combined 28 case distribution ratios much higher. Both the olanzapine-only deaths and multi-drug deaths including olanzapine cases had very similar distribution ratios of approximately 10, compared with the non-olanzapine deaths of 32. 
Discussion
In 10 cases (1-9, 28), other factors besides olanzapine contributed to the cause of death of the decedent. In eighteen cases (10-27 in Table I ), olanzapine was determined by a forensic pathologist to be a contributing factor in the cause of death. In cases 10, 15, 19, 23, 25, and 27, olanzapine was considered to be the sole cause of death (in cases 10, 19, 25, and 27, no other drugs were detected besides olanzapine).
In the other 12 multi-drug-related olanzapine cases, other drugs were present in sufficient concentrations that olanzapine was not solely responsible for the cause of death. An example would be case 11, where fluvoxamine was found in a concentration of 3.3 mg/L in PB and 79 mg/kg in the liver, along with 0.42 mg/L of oxycodone in the PB. Fluvoxamine was shown to be toxic in the range of 3.4-11 mg/L among four fatalities (16) , and blood and liver levels of another fatality were found to be 2.8 mg/L and 113 mg/kg, respectively (17) . Fluvoxamine also causes a 55% increase in olanzapine plasma concentrations during concurrent therapy, which may have been a factor in this case (18) . In cases with at least one other anti-depressant, acute oxycodone ingestion was shown in 12 deaths to be present in a range of 0.4-2.7 mg/L (19).
It appears from the postmortem redistribution data in Tables III and IV that olanzapine has a relatively small redistribution ratio in blood, compared to what is expected from many studied drugs (20) .
Toxic levels achieved from this study were similar to previous papers published on olanzapine blood and liver results. Concentrations of olanzapine associated with toxicity from this study were in the range of 1.4-6.2 mg/L (PB), 1.1-7.4 mg/L (CB), 14-88 mg/kg (liver), and 1.1-2.1 mg/L (vitreous), compared to concentrations associated with toxicity of 1.24 mg/L in blood from Stephens and co-workers (7), 4.9 mg/L in blood from Elian and colleagues (8) , 0.98 mg/L in blood from Levine and co-workers (9), 0.40 mg/L in heart blood and 0.61 mg/kg in liver from Merrick and colleagues (10), 1.38 mg/L in heart blood and 1.11 mg/L in femoral blood with a liver concentration of 6.47 mg/kg from Horak and co-workers (11) , and a mean of six cases of 1.81 mg/L in blood and 30.8 mg/kg in liver from Chue and colleagues (12) . Blood concentrations were similar in all but the two lowest reported concentrations from the cited literature, and liver concentrations match those from the average of Chue and colleagues' data (12) , but the range does not encapsulate the liver concentration of 0.61 mg/kg cited by Merrik and colleagues (10) . The case cited by Horak and co-workers (11) cites the combined effects of olanzapine and citalopram in the cause of death, and therefore concentrations should be compared to the multi-drug death liver concentration mean of 5.9 mg/kg of olanzapine in this study.
Conclusions
From the data collected in this study, olanzapine-only deaths from intentional or accidental overdose were most easily identifiable by postmortem liver concentrations, which averaged ten times the average of postmortem liver concentrations in known therapeutic-use cases, and by PB and CB levels, which averaged 12 times and 6 times higher in olanzapine-only deaths over therapeutic-use deaths, respectively. Olanzapine-only deaths were easily distinguished from multi-drug deaths involving olanzapine, because the latter average approximately twice the olanzapine blood and vitreous concentrations compared to the therapeutic use cases, and average liver concentrations between therapeutic use and multi-drug use concentrations were almost negligible. Fatal postmortem concentrations of olanzapine from this study were found to be in the range of 1.4-6.2 mg/L in PB, 1.1-7.4 mg/L in CB, 14-88 mg/kg in liver, and 1.1-2.1 mg/L in vitreous. Therapeutic-use concentrations from this study were found to be in the range of 0.11-0.43 mg/L in PB, 0-0.53 mg/L in CB, 0-8.6 mg/kg in liver, and 0-0.98 mg/L in vitreous. Concentrations between the lower ranges of the toxic level and those from therapeutic use found in these studies could not be confirmed by themselves to be toxic, but could be toxic in combination with other drugs.
